Related Experiment Video
Updated: Aug 17, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin
Wenyi Wei1, Jianping Jin, Susanne Schlisio
1Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
The c-Jun and c-Myc oncogenic transcription factors are highly unstable proteins due to polyubiquitination. Similar to c-Myc, we report here that phosphorylation of c-Jun by GSK3 creates a high-affinity binding site for the E3 ligase Fbw7, which targets c-Jun for polyubiquitination and proteasomal degradation. In keeping with this, we found that c-Jun levels were inversely related to GSK3 activity in mammalian cells that had entered the cell cycle. Importantly, phosphorylation of c-Jun by GSK3 requires a priming phosphorylation event at Ser-243. Ser-243 is mutated to phenylalanine in v-Jun and allows it to escape recognition by Fbw7. These findings explain the enhanced stability and oncogenicity of v-Jun relative to its cellular counterpart and reveal that GSK3 and Fbw7 coordinately regulate c-Jun and c-Myc.
Insights
Glycogen synthase kinase 3 (GSK3) phosphorylation targets c-Jun for degradation by the F-box and WD repeat domain-containing 7 (Fbw7) E3 ligase. This GSK3-Fbw7 pathway regulates c-Jun stability and oncogenic activity.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Biology
Background:
- c-Jun and c-Myc are oncogenic transcription factors known for their instability.
- Protein instability is often mediated by polyubiquitination and subsequent proteasomal degradation.
Purpose of the Study:
- To investigate the regulatory mechanism of c-Jun protein stability.
- To elucidate the role of GSK3 and Fbw7 in c-Jun degradation.
- To compare the stability and oncogenicity of c-Jun and v-Jun.
Main Methods:
- Phosphorylation assays to determine GSK3 activity on c-Jun.
- Ubiquitination assays to assess polyubiquitination.
- Western blotting to measure protein levels.
- Cell cycle analysis in mammalian cells.
Main Results:
- GSK3-mediated phosphorylation of c-Jun creates a binding site for the E3 ligase Fbw7.
- Fbw7 targets phosphorylated c-Jun for polyubiquitination and proteasomal degradation.
- c-Jun protein levels inversely correlate with GSK3 activity in cycling cells.
- A priming phosphorylation at Ser-243 is essential for GSK3 action.
- Mutation of Ser-243 to phenylalanine in v-Jun confers resistance to Fbw7-mediated degradation.
Conclusions:
- GSK3 and Fbw7 act in concert to regulate c-Jun stability, similar to their known role in c-Myc regulation.
- The phosphorylation status of c-Jun at Ser-243 dictates its susceptibility to Fbw7-mediated degradation.
- Enhanced stability and oncogenicity of v-Jun are attributed to its escape from GSK3/Fbw7-mediated degradation.
Related Concept Videos
Point and Frameshift Mutations
Anaphase Promoting Complex
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Restarting Stalled Replication Forks
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Spontaneous and Induced Mutations

